DNA damage in diabetes: correlation with a clinical marker

Area of Science:

• Biochemistry
• Genetics
• Endocrinology

Background:

• Diabetes mellitus is associated with increased oxidative stress.
• Oxidative stress can lead to DNA damage.
• The comet assay is a sensitive method for detecting DNA damage.

Purpose of the Study:

• To compare DNA damage levels in patients with insulin-dependent diabetes mellitus and healthy controls.
• To investigate the relationship between specific types of DNA damage and glycemic control.
• To evaluate DNA damage in lymphocytes as a marker of oxidative stress in diabetes.

Main Methods:

• Comet assay was used to measure DNA strand breaks, endonuclease III-sensitive sites (oxidized pyrimidines), and formamidopyrimidine glycosylase-sensitive sites (altered purines).
• Samples were analyzed from 10 patients with insulin-dependent diabetes mellitus and 10 matched controls.
• Correlations between DNA damage markers, body mass index, and serum glucose concentrations were assessed.

Main Results:

• Diabetic patients exhibited significantly higher mean levels of DNA strand breaks and oxidized pyrimidines compared to controls.
• DNA strand breaks correlated with body mass index in the diabetic group.
• Formamidopyrimidine glycosylase-sensitive sites showed a strong correlation with serum glucose levels, and were significantly elevated in diabetics, especially when excluding those with normal glucose.

Conclusions:

• Lymphocyte DNA damage is a valuable indicator of oxidative stress in diabetes.
• Formamidopyrimidine glycosylase-sensitive sites appear to be a specific marker for hyperglycemia-induced DNA alterations.
• These findings highlight the impact of hyperglycemia on DNA integrity in diabetic patients.